MoneyWorks4Me

Abbott India delays plans of sale/ transfer of proprietary pharma division

04 Jun 2013 Evaluate

Abbott India has decided to put on back burner the plans for sale and transfer of or other appropriate restructuring of the proprietary pharmaceuticals division (PPD) of the company. The company’s board of directors at their meeting held on June 3, 2013, decided the same. In the year ended December 31, 2012, the PPD business accounted for sales of Rs 76.22 crore which constituted of 4.73% of the net sales of Rs 1613.09 crore of the company.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services. In 1888 a young Chicago physician, Dr Wallace Calvin Abbott founded Abbott Laboratories.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..